JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NS
926
DELISTED
NuStar Energy L.P.
NS
| $54.9M | 0.01% |
1,833,360
+72,366
| +4% | +$2.35M |
|
|
HZNP
927
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $54.9M | 0.01% |
3,757,166
+316,521
| +9% | +$4.45M |
|
928
Genesis Energy
GEL
$1.84B
| $54.9M | 0.01% |
2,454,281
+251,687
| +11% | +$5.82M |
|
929
CALL
RTX Corp
RTX
$301B
| $54.7M | 0.01% |
681,840
+635,123
| +1,360% | +$48.2M |
|
930
Strategy Inc
MSTR
$38.4B
| $54.6M | 0.01% |
4,159,670
+112,090
| +3% | +$1.5M |
|
931
Antero Midstream
AM
$10.1B
| $54.3M | 0.01% |
2,751,917
+2,517,550
| +1,074% | +$46.8M |
|
932
Insulet
PODD
$9.79B
| $54.2M | 0.01% |
786,115
+174,520
| +29% | +$11.5M |
|
|
BWP
933
DELISTED
Boardwalk Pipeline Partners
BWP
| $54.2M | 0.01% |
4,200,850
+1,911,755
| +84% | +$27M |
|
934
Avery Dennison
AVY
$13.4B
| $54.2M | 0.01% |
471,676
-100,966
| -18% | -$10.9M |
|
|
THS
935
DELISTED
Treehouse Foods
THS
| $54.1M | 0.01% |
1,093,996
-2,510,122
| -70% | -$134M |
|
936
Protolabs
PRLB
$2.13B
| $54.1M | 0.01% |
525,218
-125,578
| -19% | -$11.3M |
|
937
Crown Castle
CCI
$32.2B
| $54M | 0.01% |
485,995
+198,290
| +69% | +$21.4M |
|
938
Lamb Weston
LW
$7.19B
| $53.9M | 0.01% |
955,003
+263,156
| +38% | +$13.9M |
|
|
TVPT
939
DELISTED
Travelport Worldwide Limited
TVPT
| $53.9M | 0.01% |
4,124,281
-239,041
| -5% | -$3.41M |
|
940
FirstCash
FCFS
$8.78B
| $53.7M | 0.01% |
796,702
-30,130
| -4% | -$1.95M |
|
941
HealthEquity
HQY
$8.75B
| $53.7M | 0.01% |
1,151,090
+158,271
| +16% | +$7.84M |
|
942
Cadence Design Systems
CDNS
$93.4B
| $53.6M | 0.01% |
1,282,701
+278,824
| +28% | +$12M |
|
943
Southwest Gas
SWX
$6.67B
| $53.6M | 0.01% |
678,037
-43,285
| -6% | -$3.51M |
|
944
ING
ING
$102B
| $53.6M | 0.01% |
2,905,393
+210,067
| +8% | +$3.85M |
|
945
ITT
ITT
$19.1B
| $53.4M | 0.01% |
1,000,644
+153,507
| +18% | +$7.71M |
|
946
NCR Voyix
VYX
$1.14B
| $53.3M | 0.01% |
2,558,204
+183,912
| +8% | +$3.73M |
|
947
BCE
BCE
$21.2B
| $53.3M | 0.01% |
1,109,435
+323,478
| +41% | +$15.4M |
|
948
Fastenal
FAST
$59.5B
| $53.3M | 0.01% |
3,895,336
+3,643,892
| +1,449% | +$45.1M |
|
949
Littelfuse
LFUS
$11.6B
| $53.2M | 0.01% |
268,818
+25,895
| +11% | +$5.19M |
|
|
RMP
950
DELISTED
Rice Midstream Partners LP
RMP
| $53.1M | 0.01% |
2,473,769
+149,109
| +6% | +$3.12M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.